Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Verona Pharma plc buy Piper Sandler

Start price
€0.51
23.06.25 / 50%
Target price
€139.15
23.06.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 23.06.26. The prediction end date can be changed by Piper_Sandler at any time.
Performance without dividends (%)
Name 1w 1m
Verona Pharma plc - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

Comments by Piper_Sandler for this prediction

In the thread Verona Pharma plc diskutieren
Prediction Buy
Perf. (%) -
Target price 139.152
Change
Ends at 23.06.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat